Marinus Pharmaceuticals, Inc. Financial Ratios — MRNS Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-51.4	-34.92	-45.24	-62.89	-41.03	-54.05	-62.18	-54.13	-68.76	-10	-65.7
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	- -	- -	- -	- -	- -	- -	100	90.37	98.67	93.76
EBITDA Margin (%)	-1,408.57	- -	- -	- -	- -	- -	- -	- -	-3,934.98	-629.36	-441.05	-422.52
Operating Margin (%)	-1,426.47	- -	- -	- -	- -	- -	- -	- -	-3,954.42	-631.68	-442.69	-424.3
Incremental Operating Margin (%)	- -	3,952.53	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,408.54	- -	- -	- -	- -	- -	- -	- -	-3,927.53	-643.7	-64.48	-461.27
Profit Margin (%)	-1,408.54	- -	- -	- -	- -	- -	- -	- -	-3,927.53	-643.7	-77.78	-456.31
Net Income to Common Margin (%)	-3,594.28	- -	- -	- -	- -	- -	- -	- -	-4,444.41	-643.7	-77.78	-456.31
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	60.81	41.92	19.02	- -	- -	- -	- -	- -	11.63	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	3	- -	7	7	5	- -	- -	- -	3	43	72	74
ST Debt	3	- -	- -	2	4	- -	- -	- -	1	1	1	12
LT Debt	- -	- -	7	5	2	- -	- -	- -	3	43	71	61
Total Debt/EBITDA	-1.9	- -	-0.59	-0.3	-0.19	- -	- -	-0.01	-0.05	-0.45	-0.64	-0.56
Net Debt/EBITDA	4.23	1.87	3.59	1.82	0.74	1.77	1.83	1.68	2.05	0.85	1.5	0.36
Total Debt/EBIT	-1.87	- -	-0.59	-0.3	-0.19	- -	- -	-0.01	-0.04	-0.45	-0.64	-0.56
Net Debt/EBIT	4.18	1.87	3.58	1.82	0.74	1.76	1.82	1.67	2.04	0.85	1.49	0.36
EBITDA to Interest Expense	-4.39	-59	-101.84	-51.41	-60.82	-118.97	- -	- -	- -	-37.4	-10.53	-7.75
EBITDA-CapEx/Interest Expense	-4.41	-59.19	-102.12	-52.15	-62.2	-121.81	- -	- -	- -	-38.52	-10.7	-7.76
EBIT to Interest Expense	-4.45	-59.11	-101.88	-51.44	-60.87	-119.77	- -	- -	- -	-37.54	-10.57	-7.78
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	11	17
Common Equity/Total Assets	-647.69	-520.15	-144.03	-162.9	-400.07	-238.47	-241.11	-238.31	-207.29	-300.11	-165.87	-334.61
Long-Term Debt/Equity (%)	- -	- -	17.01	11.16	8.11	- -	- -	- -	1.85	80	61.22	366.38
Long-Term Debt/Capital (%)	- -	- -	-10.72	-5.83	-1.45	- -	- -	- -	-0.83	-11.79	-20.02	-12.33
Long-Term Debt/Total Assets (%)	- -	- -	13.94	8.78	5.54	- -	- -	- -	1.68	31.27	27.37	35.94
Total Debt/Equity (%)	63.86	- -	17.01	15.69	24.41	- -	- -	0.51	2.22	81.04	61.77	439.89
Total Debt/Capital (%)	44.61	- -	-10.72	-8.2	-4.35	- -	- -	-0.22	-1	-11.94	-20.2	-14.81
Total Debt/Total Assets (%)	30.76	- -	13.94	12.35	16.67	- -	- -	0.45	2.02	31.67	27.61	43.15
Net Debt to Equity	-142.59	-106.12	-103.81	-94.54	-97.47	-57.8	-99.12	-103.62	-100.95	-153.53	-145.27	-283.91
Net Debt/Capital (%)	225.28	590.41	37.13	31.34	14.27	18.81	27.19	30.53	31.27	16.9	28.31	7.69
EBITDA	-1	-5	-12	-24	-28	-19	-37	-54	-68	-97	-112	-131
EBITDA-CapEx	-1	-5	-12	-25	-29	-19	-37	-55	-68	-99	-114	-131
Operating Income (Loss)	-1	-5	-12	-24	-28	-19	-37	-54	-68	-97	-113	-131

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	1.92	4.24	24.38	7.56	3.72	20.99	10.53	11.42	13.05	3.03	9.62	3.7
Current Ratio	1.93	4.99	24.59	7.77	3.75	21.37	10.7	11.72	13.63	3.25	10.09	4.07
Quick Ratio	1.92	4.24	24.38	7.56	3.72	20.99	10.53	11.42	13.2	3.11	9.87	3.79
CFO/Avg Current Liab	- -	-1.93	-3.9	-4.25	-3.19	-3.54	-5.89	-6.51	-6.49	-2.16	-3.44	-3.6
Common Equity/Total Assets	-647.69	-520.15	-144.03	-162.9	-400.07	-238.47	-241.11	-238.31	-207.29	-300.11	-165.87	-334.61
Long-Term Debt/Equity (%)	- -	- -	17.01	11.16	8.11	- -	- -	- -	1.85	80	61.22	366.38
Long-Term Debt/Capital (%)	- -	- -	-10.72	-5.83	-1.45	- -	- -	- -	-0.83	-11.79	-20.02	-12.33
Long-Term Debt/Total Assets (%)	- -	- -	13.94	8.78	5.54	- -	- -	- -	1.68	31.27	27.37	35.94
Total Debt/Equity (%)	63.86	- -	17.01	15.69	24.41	- -	- -	0.51	2.22	81.04	61.77	439.89
Total Debt/Capital (%)	44.61	- -	-10.72	-8.2	-4.35	- -	- -	-0.22	-1	-11.94	-20.2	-14.81
Total Debt/Total Assets (%)	30.76	- -	13.94	12.35	16.67	- -	- -	0.45	2.02	31.67	27.61	43.15
CFO/Total Liabilities	-27.3	-280.14	-94.81	-158.16	-248.49	-706.31	-402.98	-439.2	-459.26	-66.56	-78.66	-76.55
CFO/CapEx	-224.49	-389.88	-260.27	-57.18	-38.46	-41.81	-335.45	-125.34	- -	-19.2	-63.63	-991.61
Altman's Z-Score	-9.02	-7.83	-0.57	-1.28	-7.42	7.47	-1.39	-2.51	0.46	-4.84	-2.44	-5.6

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	2.09	7.18	5.68	6.11
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	174.85	50.84	64.3	59.76
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.83	1.55
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	41.33	234.97
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.55	0.11	1.01
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	659	3,320.45	361.75
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	-608.16	-3,214.82	-67.03
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.84	22.97	-175.21
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	16	28	5	48	29	29	83	109	39	146
- Cash & Cash Equivalents	9	10	50	52	26	34	68	91	139	123	241	121
+ Preferred Equity and Hybrid Capital	60	70	- -	- -	- -	- -	- -	28	4	4	4	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	- -	7	7	5	- -	- -	- -	3	43	72	74
Enterprise Value	54	60	-26	-20	-20	-5	-43	-34	-49	34	-126	70
Total Capital	6	8	-65	-90	-121	-145	-181	-207	-304	-363	-355	-498
Total Debt/Capital (%)	44.61	- -	-10.72	-8.2	-4.35	- -	- -	-0.22	-1	-11.94	-20.2	-14.81
Total Debt / EV	0.05	- -	-0.26	-0.36	-0.26	- -	- -	-0.01	-0.06	1.29	-0.57	1.06
EV/Sales	535.86	- -	- -	- -	- -	- -	- -	- -	116.55	2.19	- -	2.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	16	28	5	48	29	29	83	109	39	146
Diluted Enterprise Value	54	60	-26	-16	-16	14	-38	-33	-48	34	-126	99
EV per Share	26.58	29.67	14.51	17.47	- -	23.57	4.37	4.01	7.34	0.92	- -	1.3
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	2	15	25	31
TTM EBITDA	-1	-5	-12	-24	-28	-19	-37	-54	-68	-97	-112	-131
TTM Operating Income	-1	-5	-12	-24	-28	-19	-37	-54	-68	-97	-113	-131
TTM Cash Flow to Firm	-1	-7	-8	-20	-24	-19	-28	-49	-61	-53	-100	-101
TTM Free Cash Flow to Firm	-1	-7	-8	-19	-24	-18	-28	-48	-61	-50	-98	-101

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Free Cash Flow	- -	- -	-1.9	-1.44	-0.2	-2.61	-1.06	-0.61	-1.37	-2.07	-0.35	-1.24
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	54	60	-26	-20	-20	-5	-43	-34	-49	34	-126	70
Low Price	- -	- -	4	4.52	0.82	0.97	2.36	0.77	1.04	2.28	0.87	1
EV/Sales	535.86	- -	- -	- -	- -	- -	- -	- -	116.55	2.19	- -	2.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-0.86	-1.57	-0.54	-0.95	-1.65	-0.71	-0.9	-1.29	-3.33	-0.73
Price/Earnings High	- -	- -	-1.29	-3.11	-1.29	-3.07	-2.93	-1.36	-1.53	-1.86	-6.49	-1.07
Price/Earnings Low	- -	- -	-0.46	-0.68	-0.14	-0.3	-0.66	-0.19	-0.37	-0.85	-1.71	-0.38
Price/Book Value	- -	- -	-0.22	-0.29	-0.04	-0.33	-0.16	-0.12	-0.27	-0.27	-0.09	-0.26
Price/Book Value Average	- -	- -	-0.16	-0.4	-0.12	-0.12	-0.33	-0.16	-0.22	-0.31	-0.15	-0.18
Price/Book Value High	- -	- -	-0.24	-0.8	-0.29	-0.4	-0.59	-0.31	-0.38	-0.45	-0.3	-0.26
Price/Book Value Low	- -	- -	-0.09	-0.17	-0.03	-0.04	-0.13	-0.04	-0.09	-0.2	-0.08	-0.09
Price/Tangible Book Value	- -	- -	0.4	0.61	0.23	0.83	0.43	0.49	0.63	2.21	0.35	8.72
Price/Tangible Book Value Average	- -	- -	0.28	0.83	0.72	0.31	0.89	0.65	0.52	2.6	0.59	6.15
Price/Tangible Book Value High	- -	- -	0.42	1.65	1.72	1	1.58	1.24	0.88	3.73	1.15	9.01
Price/Tangible Book Value Low	- -	- -	0.15	0.36	0.19	0.1	0.35	0.18	0.21	1.7	0.3	3.2
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	48.41	7.1	1.53	4.72
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	40.18	8.33	2.59	3.33
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	68.1	11.97	5.05	4.87
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	16.51	5.45	1.33	1.73
Price/Cash Flow	- -	- -	-1.89	-1.42	-0.2	-2.55	-1.05	-0.61	-1.37	-1.96	-0.34	-1.24
Price/Cash Flow Average	- -	- -	-1.33	-1.93	-0.62	-0.96	-2.17	-0.79	-1.13	-2.31	-0.59	-0.87
Price/Cash Flow High	- -	- -	-2.01	-3.84	-1.49	-3.09	-3.87	-1.51	-1.92	-3.31	-1.14	-1.28
Price/Cash Flow Low	- -	- -	-0.72	-0.84	-0.16	-0.3	-0.87	-0.22	-0.47	-1.51	-0.3	-0.45
Price/Free Cash Flow Average	- -	- -	-1.34	-1.97	-0.64	-0.98	-2.18	-0.8	-1.13	-2.43	-0.59	-0.87
Price/Free Cash Flow High	- -	- -	-2.02	-3.91	-1.53	-3.16	-3.88	-1.53	-1.92	-3.49	-1.16	-1.28
Price/Free Cash Flow Low	- -	- -	-0.72	-0.85	-0.17	-0.31	-0.87	-0.22	-0.47	-1.59	-0.31	-0.45
EV/Sales Average	535.86	- -	- -	- -	- -	- -	- -	- -	84.43	3.43	3.9	1.81
EV/Sales High	535.86	- -	- -	- -	- -	- -	- -	- -	195.82	7.06	13.7	3.36
EV/Sales Low	535.86	- -	- -	- -	- -	- -	- -	- -	- -	0.54	- -	0.22
EV/EBITDA Average	-38.04	-11.14	2.63	0.22	0.19	0.82	0.2	0.44	0.92	-0.54	0.88	-0.43
EV/EBITDA High	-38.04	-11.14	2.13	-1.35	-0.56	-1.3	-1.08	-0.21	0.21	-1.12	0.32	-0.8
EV/EBITDA Low	-38.04	-11.14	3.07	1.13	0.6	1.47	1.18	0.96	1.52	-0.09	1.17	-0.05
EV/EBIT Average	-37.57	-11.12	2.62	0.22	0.19	0.81	0.2	0.44	0.91	-0.54	0.88	-0.43
EV/EBIT High	-37.57	-11.12	2.13	-1.35	-0.56	-1.29	-1.08	-0.21	0.21	-1.12	0.32	-0.79
EV/EBIT Low	-37.57	-11.12	3.07	1.13	0.6	1.46	1.17	0.95	1.51	-0.09	1.16	-0.05
Last Price	- -	- -	10.57	7.64	1.01	8.16	2.87	2.16	3.05	2.97	1	2.72
High Price	- -	- -	11.24	20.72	7.56	9.87	10.54	5.4	4.29	5.01	3.29	2.81
Enterprise Value Average	54	60	-31	-5	-5	-15	-7	-24	-62	53	-99	56
Enterprise Value High	54	60	-25	33	16	25	40	11	-14	108	-36	104
Enterprise Value Low	54	60	-37	-27	-17	-28	-44	-52	-103	8	-131	7

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	3	3	4	5	5	10	13	22	37	37	50	55
Diluted Weighted Avg Shares	2	2	2	4	5	6	10	14	27	37	39	54
Basic Weighted Avg Shares	2	2	2	4	5	6	10	14	27	37	39	54
Revenue per Share	0.05	- -	- -	- -	- -	- -	- -	- -	0.06	0.42	0.65	0.58
EBITDA per Share	-0.7	-2.66	-7.75	-6.55	-5.79	-3.21	-3.62	-3.97	-2.48	-2.63	-2.88	-2.44
Operating Income per Share	-0.71	-2.67	-7.75	-6.55	-5.79	-3.24	-3.64	-3.99	-2.49	-2.64	-2.89	-2.45
Basic EPS, GAAP	-1.78	-4.5	-8.7	-6.66	-5.88	-3.21	-3.59	-3.97	-2.8	-2.69	-0.51	-2.63
Basic EPS from Cont Ops	-0.7	-2.61	-7.04	-6.66	-5.88	-3.21	-3.59	-3.97	-2.47	-2.69	-0.51	-2.63
Diluted EPS, GAAP	-1.78	-4.5	-8.7	-6.66	-5.88	-3.21	-3.59	-3.97	-2.8	-2.69	-0.51	-2.63
Diluted EPS from Cont Ops	-0.7	-2.61	-7.04	-6.66	-5.88	-3.21	-3.59	-3.97	-2.47	-2.69	-0.51	-2.63
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.61	-3.29	-5.58	-5.4	-5.08	-3.2	-2.72	-3.57	-2.23	-1.51	-2.89	-2.2
Free Cash Flow per Basic Share	-0.61	-3.3	-5.61	-5.49	-5.21	-3.27	-2.73	-3.6	-2.23	-1.59	-2.93	-2.2
Cash & Equivalents per Share	4.28	4.98	32.32	15.07	6.17	9.07	7.11	6.73	5.13	3.35	6.16	2.8
Book Value per Share	-27.9	-30.51	-47.02	-26.05	-25.81	-24.58	-17.74	-17.28	-11.44	-11.2	-11.02	-10.64
Tangible Book Value per Share	-27.47	-29.95	26.76	12.58	4.41	9.86	6.68	4.37	4.87	1.34	2.87	0.31

Marinus Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)